Proud to see Dr. Pedro Barata and team receiving national media coverage for their groundbreaking work. @UHhospitals Seidman Cancer Center will be the first participant in the first late-phase trial testing probiotics as a way to amplify cancer treatment. cnn.com/2026/06/05/health/guโฆ
An Investigator-initiated, phase II trial in "MTAP deleted Malignant Peripheral Nerve Sheath Tumor (MPNST)"launching @UHhospitals@caseccc in #Cleveland, #Ohio. BMS-986504 from @bmsnews shows promising activity in MTAP-deleted tumors in phase 1 trials. #NCT07549022